Literature DB >> 2032230

Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas.

T Sano1, T Tsujino, K Yoshida, H Nakayama, K Haruma, H Ito, Y Nakamura, G Kajiyama, E Tahara.   

Abstract

Recently, loss or inactivation of genes at specific chromosomal loci has been considered to be one of the important mechanisms during the development of human tumors. In order to identify tumor suppressor genes for gastric carcinoma, we performed restriction fragment length polymorphism analysis on 48 human gastric carcinomas. Allele losses were investigated for 14 specific loci on chromosomes 1, 5, 6, 7, 10, 11, 12, and 17. Loss of heterozygosity on chromosome 17p13.1 (p53 locus) was detected in 13 (68%) of 19 informative cases. Well-differentiated adenocarcinoma showed high frequencies of allele losses on chromosomes 5q (60%) and 17p (67%) in early cancers and on chromosomes 1q (67%), 5q (36%), 7p (33%), 7q (39%), and 17p (73%) in advanced cancers. In poorly differentiated adenocarcinomas, loss of heterozygosity was detected on chromosomes 1p (38%), 12q (31%), and 17p (60%). Allele losses on chromosomes 1q, 5q, and 7p were not detected in poorly differentiated adenocarcinoma, their frequencies being significantly different between the two histological types. These results suggest that allele loss on chromosome 17p is a common event in gastric carcinoma, regardless of histological type, and that allele loss on chromosome 5q may play a role in the carcinogenesis of well-differentiated adenocarcinoma. Additionally, allele losses on chromosomes 1q and 7p may be involved in the progression of well-differentiated adenocarcinoma.

Entities:  

Mesh:

Year:  1991        PMID: 2032230

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  60 in total

1.  Multiple genetic alterations and behavior of cellular biology in gastric cancer and other gastric mucosal lesions:H.pylori infection, histological types and staging.

Authors:  Heng-Jun Gao; Lian-Zhen Yu; Jian-Feng Bai; Yan-Shen Peng; Gu Sun; Han-Lin Zhao; Kun Miu; Xiu-Zhen L ; Xiao-Yong Zhang; Zhi-Quan Zhao
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

2.  Analysis of chromosome 17p13 (p53 locus) alterations in gastric carcinoma cells by dual-color fluorescence in situ hybridization.

Authors:  M Kobayashi; A Kawashima; M Mai; A Ooi
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

3.  Microsatellite instability and loss of heterozygosity in gastric carcinoma in comparison to family history.

Authors:  G Keller; M Rudelius; H Vogelsang; V Grimm; M G Wilhelm; J Mueller; J R Siewert; H Höfler
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

4.  Chromosomal alterations in paired gastric adenomas and carcinomas.

Authors:  Y H Kim; N G Kim; J G Lim; C Park; H Kim
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

5.  Alterations in p53 predict response to preoperative high dose chemotherapy in patients with gastric cancer.

Authors:  F Bataille; P Rümmele; W Dietmaier; D Gaag; F Klebl; A Reichle; P Wild; F Hofstädter; A Hartmann
Journal:  Mol Pathol       Date:  2003-10

6.  Polymerase chain reaction-single strand conformation polymorphism analysis of the p53 gene in paraffin-embedded surgical material from human renal cell carcinomas.

Authors:  Y Kikuchi; T Kishi; M Suzuki; M Furusato; S Aizawa
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

Review 7.  Potentially resectable gastric carcinoma: current approaches to staging and preoperative therapy.

Authors:  J A Ajani; P F Mansfield; D M Ota
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

8.  Comparative analysis of p53 and c-myc expression and cell proliferation in human hepatocellular carcinomas--an enhanced immunohistochemical approach.

Authors:  M Saegusa; Y Takano; H Kishimoto; G Wakabayashi; K Nohga; M Okudaira
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

9.  Loss of heterozygosity and K-ras gene mutations in gastric cancer.

Authors:  G N Ranzani; B Renault; N S Pellegata; P Fattorini; E Magni; F Bacci; D Amadori
Journal:  Hum Genet       Date:  1993-10-01       Impact factor: 4.132

10.  Mouse gastric tumor models with prostaglandin E2 pathway activation show similar gene expression profiles to intestinal-type human gastric cancer.

Authors:  Hiraku Itadani; Hiroko Oshima; Masanobu Oshima; Hidehito Kotani
Journal:  BMC Genomics       Date:  2009-12-17       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.